With this agreement LCC is supporting a translational therapy project entirely based on an Italian research

Milano, 21 febbraio 2020

The Board of Directors of Life Care Capital S.p.A. (the “Company” or “LCC”), a SPAC (Special Purpose Acquisition Company) with ordinary shares and warrants admitted to trading on the AIM Italia, has approved today the business combination transaction (the “Business Combination”, or the “Relevant Transaction”) with Biogenera S.p.A. (“Biogenera”).